A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would cover the $2 million price tag.
A new class of life-saving drugs is helping children who once had no hope. But some carry a price tag of millions for a ...
An experimental gene therapy treatment created at UCLA gave a "bubble girl" born with a rare genetic disorder a new life.
The donation from Don and Anne Edwards aims to speed research, treatment and diagnosis for children with rare and genetic ...
Wedbush upgrades Sarepta Therapeutics, citing overdone selloff and potential upside as FDA could re-approval Elevidys for non ...
Capricor Therapeutics’ stock has soared by more than 370% after a pivotal trial of its Duchenne muscular dystrophy (DMD) cell ...
A regimen of three immune-suppressing drugs may improve the effectiveness of gene therapy for people with DMD, research in ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.’s (NASDAQ: SRPT) Cohort 8 of ENDEAVOR (Study 9001-103). • SRPT shares are advancing steadily. Get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback